Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.20%
SPX
-0.64%
IXIC
-1.15%
FTSE
-0.32%
N225
-0.26%
AXJO
-0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

Argenx SE (ARGX) Reports Positive Vyvgart Trial Results for Autoimmune Treatment in gMG

about 6 hours ago
publisher logo
Cashu

Argenx SE: Analyst Sentiment Highlights Opportunities and Challenges in Biotechnology Sector

1 day ago
publisher logo
Cashu

Argenx SE (ARGX): Analyst Opinions Highlight Mixed Outlook in Biotechnology Sector

3 days ago

Key Stats

Market Cap
42.10B
Dividend Yield
0.00%
P/E Ratio
43.41
EPS
-2.70
Revenue
122.97M
Avg. Volume
383.19K

About

What does ARGX do?
It seems that there is no specific content provided for summarization. Please share the content you would like summarized, and I'll be happy to help!
Sector
💻 Health Care
IPO
CEO
Employees
1,599
Headquarters
Belgium
Website
http://www.argenx.com
Stocks
Health Care
argx
Argen X SE
NYSE EURONEXT - EURONEXT BRUSSELS: ARGX
+8.31 (+1.18%)
712.38
USD
At close at Aug 29, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials